KID抗体

+ +

•  

   

     Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);    

  
  

•  

   

     Western blot analysis using KID mouse mAb against MCF-7 (1) and Hela (2) cell lysate.    

  
  

•  

   

     Immunohistochemical analysis of paraffin-embedded human cervical cancer tissues using KID mouse mAb with DAB staining.    

  
  

•  

   

     Immunohistochemical analysis of paraffin-embedded human rectum cancer tissues using KID mouse mAb with DAB staining.    

  
  

**Background of KID Antibody**

KID antibody is associated with research on Keratosis-Ichthyosis-Deafness (KID) syndrome, a rare genetic disorder caused by mutations in the *GJB2* gene, which encodes connexin 26 (Cx26), a gap junction protein critical for intercellular communication. These mutations, often affecting the extracellular or transmembrane domains of Cx26. disrupt skin barrier function, keratinocyte differentiation, and inner ear homeostasis, leading to hyperkeratosis, erythrokeratoderma, and sensorineural hearing loss.

KID antibodies are primarily used as research tools to study aberrant Cx26 expression, localization, or function in cellular and animal models. They help elucidate pathogenic mechanisms, such as impaired ion transport or dysregulated cell signaling, contributing to the syndrome’s clinical features. Additionally, some studies explore autoantibodies in KID patients, though their role remains unclear.

Beyond KID syndrome, antibodies targeting connexins are investigated in other skin disorders and hearing impairments. However, KID-specific antibodies hold unique value in dissecting genotype-phenotype correlations and potential therapeutic strategies, including gene therapy or pharmacological modulation of gap junctions. Their development underscores the intersection of dermatology, genetics, and molecular biology in addressing rare diseases.